Genedx Holdings Corp (WGS)

$161.95 +1.57 (0.98%)
Market Cap 4.64B
Revenue (ttm) 305.45M
Net Income (ttm) -52.29M
EPS (ttm) N/A
PE Ratio 81.52
Forward PE 263.28
Profit Margin -17.12%
Debt to Equity Ratio 0.18
Volume 246,400
Avg Vol 539,470
Day's Range N/A - N/A
Shares Out 28.91M
Stochastic %K 76%
Beta 1.99
Analysts Strong Sell
Price Target $157.88

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
AtomicAIerts
AtomicAIerts Dec. 5 at 8:08 AM
$WGS AtomicAlerts Scalp Alert Direction: LONG Entry: $161.84 TP1: $162.54 | TP2: $163.24 | TP3: $163.94 Stop Loss: $161.24 👉 https://atomicalerts.com
0 · Reply
Iightning
Iightning Dec. 5 at 3:06 AM
1ightning® Premium Options Alert (Actionable) Ticker: $WGS Contract: Dec 19 $165C Entry: 7.05 Exit: 12.70 Return: +80.16% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 9:40 PM
1ightning® Premium Options Alert (Actionable) Ticker: $WGS Contract: Dec 19 $165C Entry: 7.05 Exit: 12.70 Return: +80.16% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Macarran
Macarran Dec. 4 at 8:43 PM
$WGS https://www.investing.com/news/insider-trading-news/feeley-genedx-cfo-sells-61276-in-wgs-stock-93CH-4389454
0 · Reply
CarverX
CarverX Dec. 4 at 3:59 PM
$WGS 🚀🚀🚀 https://www.tipranks.com/news/wgs-wrd-irdm-cathie-wood-ramps-up-buying-in-genedx-and-weride-trims-exposure-in-iridium-stock
0 · Reply
Iightning
Iightning Dec. 4 at 5:22 AM
1ightning® Premium Options Alert (Actionable) Ticker: $WGS Contract: Dec 19 $165C Entry: 7.00 Exit: 9.74 Return: +39.09% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 3 at 9:29 AM
1ightning® Premium Options Alert (Actionable) Ticker: $WGS Contract: Dec 19 $97.5C Entry: 33.15 Exit: 65.86 Return: +98.66% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Macarran
Macarran Dec. 2 at 5:26 PM
$WGS https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-genedx-holdings-corp-shareholders-to-contact-the-firm-to-discuss-their-rights-302628354.html
0 · Reply
MaverikIT
MaverikIT Dec. 2 at 3:02 PM
$WGS +5.49 - yo who said this is 'tra$H" ? eyeing 52wk$ again
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 2:49 AM
$WELL $WFC $WFRD $WGMI $WGS
0 · Reply
Latest News on WGS
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Nov 30, 2025, 3:20 PM EST - 4 days ago

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

6 Healthcare Stocks With Strong Upward Momentum

Nov 18, 2025, 12:59 PM EST - 16 days ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN GH MEDP

BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit?

Nov 14, 2025, 1:51 PM EST - 20 days ago

BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit?

Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing

Nov 11, 2025, 9:58 AM EST - 23 days ago

Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

Nov 6, 2025, 8:00 AM EST - 4 weeks ago

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

GeneDx to Participate in Upcoming Investor Conferences

Nov 4, 2025, 8:00 AM EST - 4 weeks ago

GeneDx to Participate in Upcoming Investor Conferences

GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 3:41 PM EDT - 5 weeks ago

GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Oct 28, 2025, 6:30 AM EDT - 5 weeks ago

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth

Oct 27, 2025, 8:00 AM EDT - 5 weeks ago

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

Oct 27, 2025, 8:00 AM EDT - 5 weeks ago

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Oct 24, 2025, 9:40 AM EDT - 5 weeks ago

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

Oct 22, 2025, 8:00 AM EDT - 6 weeks ago

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

Oct 20, 2025, 8:00 AM EDT - 6 weeks ago

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

Oct 15, 2025, 3:30 PM EDT - 7 weeks ago

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Oct 15, 2025, 11:45 AM EDT - 7 weeks ago

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Oct 15, 2025, 9:15 AM EDT - 7 weeks ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

ILMN

GeneDx's Blueprint For The Next Healthcare Revolution

Oct 15, 2025, 2:55 AM EDT - 7 weeks ago

GeneDx's Blueprint For The Next Healthcare Revolution

How GeneDX CEO Katherine Stueland is using AI to save lives

Oct 14, 2025, 3:17 PM EDT - 7 weeks ago

How GeneDX CEO Katherine Stueland is using AI to save lives

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

Oct 14, 2025, 8:00 AM EDT - 7 weeks ago

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

Oct 13, 2025, 8:00 AM EDT - 7 weeks ago

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

Oct 9, 2025, 8:00 AM EDT - 2 months ago

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

Oct 8, 2025, 8:00 AM EDT - 2 months ago

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

Oct 7, 2025, 8:00 AM EDT - 2 months ago

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Oct 1, 2025, 4:01 PM EDT - 2 months ago

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

Sep 30, 2025, 8:00 AM EDT - 2 months ago

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

Sep 25, 2025, 8:00 AM EDT - 2 months ago

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

Sep 18, 2025, 8:00 AM EDT - 2 months ago

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 10:45 AM EDT - 3 months ago

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Seer Appoints Isaac Ro to its Board of Directors

Sep 2, 2025, 7:00 AM EDT - 3 months ago

Seer Appoints Isaac Ro to its Board of Directors

SEER

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

Aug 6, 2025, 9:30 AM EDT - 4 months ago

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

Jul 31, 2025, 10:22 AM EDT - 4 months ago

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

Jul 31, 2025, 3:30 AM EDT - 4 months ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

Why GeneDx Holdings Stock Crushed It Again Today

Jul 30, 2025, 8:00 PM EDT - 4 months ago

Why GeneDx Holdings Stock Crushed It Again Today

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

Jul 30, 2025, 5:07 PM EDT - 4 months ago

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

Jul 30, 2025, 8:38 AM EDT - 4 months ago

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

Why GeneDx Holdings Stock Blasted 8% Higher Today

Jul 29, 2025, 7:13 PM EDT - 4 months ago

Why GeneDx Holdings Stock Blasted 8% Higher Today

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 5:06 PM EDT - 4 months ago

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights

Jul 29, 2025, 6:30 AM EDT - 4 months ago

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

Jul 28, 2025, 9:43 AM EDT - 4 months ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

GeneDx CFO Sells More Than Half of His Shares

Jul 25, 2025, 2:40 PM EDT - 4 months ago

GeneDx CFO Sells More Than Half of His Shares

GeneDx: Strong Testing Volume And An Invaluable Genomic Database

Jul 15, 2025, 2:52 AM EDT - 5 months ago

GeneDx: Strong Testing Volume And An Invaluable Genomic Database

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

Jul 10, 2025, 8:30 AM EDT - 5 months ago

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

Why GeneDX Stock Surged Higher This Week

Jun 27, 2025, 7:45 AM EDT - 5 months ago

Why GeneDX Stock Surged Higher This Week

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

Jun 25, 2025, 8:30 AM EDT - 5 months ago

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

Jun 23, 2025, 3:17 PM EDT - 5 months ago

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

AtomicAIerts
AtomicAIerts Dec. 5 at 8:08 AM
$WGS AtomicAlerts Scalp Alert Direction: LONG Entry: $161.84 TP1: $162.54 | TP2: $163.24 | TP3: $163.94 Stop Loss: $161.24 👉 https://atomicalerts.com
0 · Reply
Iightning
Iightning Dec. 5 at 3:06 AM
1ightning® Premium Options Alert (Actionable) Ticker: $WGS Contract: Dec 19 $165C Entry: 7.05 Exit: 12.70 Return: +80.16% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 9:40 PM
1ightning® Premium Options Alert (Actionable) Ticker: $WGS Contract: Dec 19 $165C Entry: 7.05 Exit: 12.70 Return: +80.16% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Macarran
Macarran Dec. 4 at 8:43 PM
$WGS https://www.investing.com/news/insider-trading-news/feeley-genedx-cfo-sells-61276-in-wgs-stock-93CH-4389454
0 · Reply
CarverX
CarverX Dec. 4 at 3:59 PM
$WGS 🚀🚀🚀 https://www.tipranks.com/news/wgs-wrd-irdm-cathie-wood-ramps-up-buying-in-genedx-and-weride-trims-exposure-in-iridium-stock
0 · Reply
Iightning
Iightning Dec. 4 at 5:22 AM
1ightning® Premium Options Alert (Actionable) Ticker: $WGS Contract: Dec 19 $165C Entry: 7.00 Exit: 9.74 Return: +39.09% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 3 at 9:29 AM
1ightning® Premium Options Alert (Actionable) Ticker: $WGS Contract: Dec 19 $97.5C Entry: 33.15 Exit: 65.86 Return: +98.66% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Macarran
Macarran Dec. 2 at 5:26 PM
$WGS https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-genedx-holdings-corp-shareholders-to-contact-the-firm-to-discuss-their-rights-302628354.html
0 · Reply
MaverikIT
MaverikIT Dec. 2 at 3:02 PM
$WGS +5.49 - yo who said this is 'tra$H" ? eyeing 52wk$ again
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 2:49 AM
$WELL $WFC $WFRD $WGMI $WGS
0 · Reply
Iightning
Iightning Dec. 1 at 11:35 PM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $WGS **Contract:** Dec 12 $165C **Entry:** 8.55 **Exit:** 13.79 **Return:** **+61.28% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
MaverikIT
MaverikIT Dec. 1 at 12:41 AM
$WGS nice
0 · Reply
tymtested
tymtested Nov. 30 at 11:34 PM
$WGS I like this stock and company, however assume a 30 pe and earnings would need to be $5.55 per share annually to justify current stock price.
1 · Reply
CarverX
CarverX Nov. 26 at 8:52 PM
$WGS Happy Thanksgiving 🦃 Weggies (WGS fan club). Much to be thankful for 🚀🚀🚀
0 · Reply
MaverikIT
MaverikIT Nov. 26 at 3:42 PM
$WGS -0.03 - giving back today - heck NO ! $TEM - yo
0 · Reply
Iightning
Iightning Nov. 26 at 2:24 AM
1ightning® Options Trade Alert (Actionable) | Buy $WGS Dec 5 $165 Call | Enter: $4.38 Exit: $5.80 | Profit: 32.51% ROI | https://1ightning.com
0 · Reply
ajobst
ajobst Nov. 26 at 2:21 AM
$WGS So, what to people think, could this be a target for big pharma (especially after the ABT purchase of EXAS)?
0 · Reply
invest2bfree
invest2bfree Nov. 26 at 1:10 AM
$WGS had to, but I know what you mean
0 · Reply
StockbobSquaregainz
StockbobSquaregainz Nov. 25 at 9:33 PM
$WGS damn, high volume in the warrants and big drop. Looks like someone unloaded… maybe tax loss. Odd timing with the commons on a run
3 · Reply
JFDI
JFDI Nov. 25 at 9:18 PM
$WGS baby baby
1 · Reply
CarverX
CarverX Nov. 25 at 6:22 PM
$WGS Not selling a single share until $245 🚀🚀🚀 Buy the dips and hold has been the pay off strategy for this stock 🚀🚀🚀
0 · Reply
CarverX
CarverX Nov. 25 at 6:15 PM
$WGS 🚀🚀🚀
0 · Reply